{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-122777","form_type":"8-K","ticker":"OFIX","cik":"0000884624","company_name":"Orthofix Medical Inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.256953+00:00","generated_at":"2026-05-30T04:10:31.170153+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Orthofix Q3 net sales $196.6M (+7%), adjusted EBITDA $19.2M, introduces 2027 targets","bullets":["Net sales $196.6M, +7% YoY; U.S. Spine Fixation +18%, U.S. Orthopedics record quarter +15%.","Net loss $(27.4)M vs $(28.9)M prior year; adjusted EBITDA $19.2M, margin 9.8% vs 7.3%.","Free cash flow positive $5.9M in Q3; new $275M credit facility announced.","Reiterates FY2024 guidance: net sales $795-800M, adjusted EBITDA $64-69M.","Introduces 2027 targets: 6-7% revenue CAGR, mid-teens adjusted EBITDA margin, positive FCF."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-122777","json":"https://secwatch.observer/filing/0000950170-24-122777.json","markdown":"https://secwatch.observer/filing/0000950170-24-122777.md","text":"https://secwatch.observer/filing/0000950170-24-122777.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/884624/000095017024122777/0000950170-24-122777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/884624/000095017024122777/ofix-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:10:31.170153+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}